Annual CFF
$15.64 M
+$14.29 M+1063.99%
31 December 2023
Summary:
Dare Bioscience annual cash flow from financing activities is currently $15.64 million, with the most recent change of +$14.29 million (+1063.99%) on 31 December 2023. During the last 3 years, it has fallen by -$9.49 million (-37.78%). DARE annual CFF is now -79.38% below its all-time high of $75.85 million, reached on 31 December 2021.DARE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$436.40 K
+$321.00 K+278.16%
30 September 2024
Summary:
Dare Bioscience quarterly cash flow from financing activities is currently $436.40 thousand, with the most recent change of +$321.00 thousand (+278.16%) on 30 September 2024. Over the past year, it has dropped by -$8.14 million (-94.91%). DARE quarterly CFF is now -99.27% below its all-time high of $60.03 million, reached on 30 June 2014.DARE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$5.88 M
-$8.14 M-58.08%
30 September 2024
Summary:
Dare Bioscience TTM cash flow from financing activities is currently $5.88 million, with the most recent change of -$8.14 million (-58.08%) on 30 September 2024. Over the past year, it has dropped by -$4.45 million (-43.11%). DARE TTM CFF is now -92.25% below its all-time high of $75.85 million, reached on 31 December 2021.DARE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DARE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1064.0% | -94.9% | -43.1% |
| 3 y3 years | -37.8% | -98.8% | -91.4% |
| 5 y5 years | +54.6% | +100.0% | +14.1% |
DARE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -79.4% | +1064.0% | -98.8% | -92.3% | +337.3% | |
| 5 y | 5 years | -79.4% | +1064.0% | -98.8% | -92.3% | +337.3% | |
| alltime | all time | -79.4% | +9988.5% | -99.3% | +122.2% | -92.3% | +493.0% |
Dare Bioscience Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $436.40 K(+278.2%) | $5.88 M(-58.1%) |
| June 2024 | - | $115.40 K(+724.3%) | $14.02 M(-2.3%) |
| Mar 2024 | - | $14.00 K(-99.7%) | $14.35 M(-8.2%) |
| Dec 2023 | $15.64 M(+1064.0%) | $5.31 M(-38.1%) | $15.64 M(+51.4%) |
| Sept 2023 | - | $8.58 M(+1796.6%) | $10.33 M(+488.1%) |
| June 2023 | - | $452.20 K(-65.2%) | $1.76 M(-33.6%) |
| Mar 2023 | - | $1.30 M(>+9900.0%) | $2.64 M(+96.7%) |
| Dec 2022 | $1.34 M(-98.2%) | $0.00(-100.0%) | $1.34 M(-92.3%) |
| Sept 2022 | - | $4500.00(-99.7%) | $17.35 M(-67.0%) |
| June 2022 | - | $1.34 M(>+9900.0%) | $52.56 M(-18.5%) |
| Mar 2022 | - | $0.00(-100.0%) | $64.47 M(-15.0%) |
| Dec 2021 | $75.85 M(+201.8%) | $16.00 M(-54.6%) | $75.85 M(+11.1%) |
| Sept 2021 | - | $35.22 M(+165.7%) | $68.30 M(+77.5%) |
| June 2021 | - | $13.25 M(+16.5%) | $38.48 M(+29.9%) |
| Mar 2021 | - | $11.37 M(+34.5%) | $29.62 M(+17.9%) |
| Dec 2020 | $25.13 M(+387.8%) | $8.45 M(+56.6%) | $25.13 M(+50.7%) |
| Sept 2020 | - | $5.40 M(+23.0%) | $16.68 M(+47.9%) |
| June 2020 | - | $4.39 M(-36.3%) | $11.28 M(-6.3%) |
| Mar 2020 | - | $6.89 M(>+9900.0%) | $12.04 M(+133.7%) |
| Dec 2019 | $5.15 M(-49.1%) | $0.00(0.0%) | $5.15 M(+0.0%) |
| Sept 2019 | - | $0.00(-100.0%) | $5.15 M(+1.6%) |
| June 2019 | - | $5.15 M(>+9900.0%) | $5.07 M(-5999.9%) |
| Mar 2019 | - | $0.00(-100.0%) | -$85.90 K(-100.8%) |
| Dec 2018 | $10.11 M | -$2500.00(-96.9%) | $10.11 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$81.20 K(+3590.9%) | $10.11 M(-0.8%) |
| June 2018 | - | -$2200.00(-100.0%) | $10.20 M(-0.6%) |
| Mar 2018 | - | $10.20 M(>+9900.0%) | $10.25 M(+6514.7%) |
| Dec 2017 | $155.00 K(-21.5%) | $0.00(0.0%) | $155.00 K(-56.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $352.50 K(-91.6%) |
| June 2017 | - | $55.00 K(-45.0%) | $4.21 M(+92.4%) |
| Mar 2017 | - | $100.00 K(-49.4%) | $2.19 M(+1008.1%) |
| Dec 2016 | $197.50 K(-99.7%) | $197.50 K(-94.9%) | $197.50 K(-97.0%) |
| Sept 2016 | - | $3.86 M(-296.1%) | $6.60 M(+127.8%) |
| June 2016 | - | -$1.97 M(+4.1%) | $2.90 M(-93.1%) |
| Mar 2016 | - | -$1.89 M(-128.7%) | $42.13 M(-26.3%) |
| Dec 2015 | $57.13 M(-12.0%) | $6.60 M(+4130.8%) | $57.13 M(+15.1%) |
| Sept 2015 | - | $156.00 K(-99.6%) | $49.64 M(+2.1%) |
| June 2015 | - | $37.27 M(+184.2%) | $48.63 M(-31.9%) |
| Mar 2015 | - | $13.11 M(-1565.0%) | $71.39 M(+10.0%) |
| Dec 2014 | $64.93 M(+1102.0%) | -$895.00 K(+5.4%) | $64.93 M(+0.4%) |
| Sept 2014 | - | -$849.00 K(-101.4%) | $64.68 M(-12.1%) |
| June 2014 | - | $60.03 M(+802.6%) | $73.57 M(+475.5%) |
| Mar 2014 | - | $6.65 M(-678.8%) | $12.78 M(+136.7%) |
| Dec 2013 | $5.40 M(-76.0%) | -$1.15 M(-114.3%) | $5.40 M(-17.5%) |
| Sept 2013 | - | $8.05 M(-1154.5%) | $6.55 M(-538.2%) |
| June 2013 | - | -$763.00 K(+4.2%) | -$1.50 M(+104.2%) |
| Mar 2013 | - | -$732.00 K | -$732.00 K |
| Dec 2012 | $22.55 M | - | - |
FAQ
- What is Dare Bioscience annual cash flow from financing activities?
- What is the all time high annual CFF for Dare Bioscience?
- What is Dare Bioscience annual CFF year-on-year change?
- What is Dare Bioscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dare Bioscience?
- What is Dare Bioscience quarterly CFF year-on-year change?
- What is Dare Bioscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dare Bioscience?
- What is Dare Bioscience TTM CFF year-on-year change?
What is Dare Bioscience annual cash flow from financing activities?
The current annual CFF of DARE is $15.64 M
What is the all time high annual CFF for Dare Bioscience?
Dare Bioscience all-time high annual cash flow from financing activities is $75.85 M
What is Dare Bioscience annual CFF year-on-year change?
Over the past year, DARE annual cash flow from financing activities has changed by +$14.29 M (+1063.99%)
What is Dare Bioscience quarterly cash flow from financing activities?
The current quarterly CFF of DARE is $436.40 K
What is the all time high quarterly CFF for Dare Bioscience?
Dare Bioscience all-time high quarterly cash flow from financing activities is $60.03 M
What is Dare Bioscience quarterly CFF year-on-year change?
Over the past year, DARE quarterly cash flow from financing activities has changed by -$8.14 M (-94.91%)
What is Dare Bioscience TTM cash flow from financing activities?
The current TTM CFF of DARE is $5.88 M
What is the all time high TTM CFF for Dare Bioscience?
Dare Bioscience all-time high TTM cash flow from financing activities is $75.85 M
What is Dare Bioscience TTM CFF year-on-year change?
Over the past year, DARE TTM cash flow from financing activities has changed by -$4.45 M (-43.11%)